We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cls Holdings Plc | LSE:CLI | London | Ordinary Share | GB00BF044593 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.60 | 4.32% | 87.00 | 87.10 | 87.40 | 88.60 | 84.00 | 84.00 | 773,512 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 113M | -249.8M | -0.6286 | -1.39 | 346.94M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/11/2020 16:10 | Hi EI, Yes, the AZ news was the first bit of negativity since 9/11. I think now the key is just to sit and wait for the re-rating. That's what I'm aiming to do. See today that TRCS are quoting to manage the Covid vaccination traffic and venue set ups as they are experts in large gathering logistics. | simon gordon | |
27/11/2020 15:56 | Hi Simon, as mentioned on SHA, sentiment looked overbaked on some cyclicals earlier this week. The Oxford/AZN news won't have helped and vaccine news drives a lot of short term price moves atm. EU exit still unresolved is also arguably a factor. CLS is also given to rapid % moves, sometimes appearing out of thin air. | essentialinvestor | |
27/11/2020 15:52 | Quite a few smaller property plays getting hit today. Maybe a big note out on the sector which is bearish? | simon gordon | |
27/11/2020 15:44 | MCKW getting hit hard. Was not that impressed by their recent update as mentioned. | essentialinvestor | |
27/11/2020 13:11 | Bought a few for my better half. One aspect which really struck me having read some presentations Is their cost of space appears very low. If corporates are looking to reduce costs, CLS arguably should benefit. The IR site is worth checking out, for anyone particularly interested. | essentialinvestor | |
27/11/2020 11:43 | And getting quickly cheaper. As mentioned recently, when this falls, it tends to fall fast!. That may possibly be a result of more limited liquidity with the large family holdings. | essentialinvestor | |
27/11/2020 11:34 | Added , still way too cheap. | its the oxman | |
27/11/2020 09:29 | Had another small amount. | essentialinvestor | |
27/11/2020 09:12 | The market has aggressively re-rated some economically sensitive stocks as if we are about to revert back to a December 2019 economy. That ain't happening anytime soon for many businesses. "snap back to reality, ope there goes gravity". | essentialinvestor | |
26/11/2020 20:30 | Some of those vaccine news rises looking a tad exposed to me. | essentialinvestor | |
26/11/2020 17:32 | Brought few at 212p, not risen as much as others from prevaccine news levels | hindsight | |
26/11/2020 16:29 | Higher trading range rejected?. Bought a small amount back sold over 2.21. | essentialinvestor | |
20/11/2020 16:27 | Weak into the close two days running, strange. | spooky | |
19/11/2020 21:26 | But on fairly low volume. The 60K plus UT trade at 216p (shown as a buy) was probably a 'sell'. | acol | |
19/11/2020 21:06 | Doing it's usual. | essentialinvestor | |
16/11/2020 18:31 | I sold a few today, find it a tad difficult to call atm. Onwards or fall back?. Problem is CLS can fall incredibly quickly as most will be aware. | essentialinvestor | |
16/11/2020 16:21 | I agree with you that it is difficult to call and especially difficult to read the high volume trades (I don't have level 3 info) that feature from time to time. My natural preference with shares is to buy and hold (in the absence of specific news). However, this strategy had to change with Covid and I have traded this share 3 times in as many month There has been clearly identifiable trading ranges aside from the late 180's to about 210 ish. Now it has broken above 217 but will it hold. If so then we may get to around the 250 mark. | acol | |
16/11/2020 14:10 | Testing the top of the range this with the price currently at 222p. Hard to read this one, so lumpy like RM. Watching that earlier and it's run away without me *insert expletive* Watching here for a breakout. Wider market bullish move could flow through. I'd exit for a small loss if breakout didn't hold on the day. It can fall as quickly as it can rise this - nutty spikes both ways. Clearly a complete short term trading based view here. | sphere25 | |
16/11/2020 13:50 | I repurchased 75% of my original holding in 2 traunches at an average price of about 213p. The deciding factor for me was the announcement of the vaccine, a factor that has had no real impact on its share price. The main risks for me is whether or not Covid will have a major impact on firms deciding to let staff work from home in the future, post Covid. Even with blue chip clients, such working change could have a major impact on firms specialising in leasing out office space. With its portfolio spread between several countries I am not sure that a successful Brexit deal will have a huge impact on CLI share price. I agree with the OXMAN that the share price should be closer to 250p. | acol | |
16/11/2020 10:50 | OX, Brexit trade deal needed for those levels imv. We zre in a holding pattern atm. | essentialinvestor | |
16/11/2020 10:15 | Surprised this isn't a bit closer to 250p. Suspect a further rise will come. | its the oxman | |
23/10/2020 17:57 | Still not gone below 1.90. | essentialinvestor | |
20/10/2020 10:05 | Yes there are risks, I've highlighted the future of the office debate on other boards. In terms of CLS, a case of whether this is reflected in the current NAV discount, or not. Their longer term record is strong, but past performance is not a guide to...etc. Very much a case of DYOR. | essentialinvestor | |
20/10/2020 08:37 | Almost all the portfolio is offices so it must be high risk. | giant slalom | |
16/10/2020 15:39 | Under cicra £1.90 looks reasonable risk/reward imv. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions